Federated Hermes, Inc. Eledon Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.45 - $3.88 $164 - $259	-67 Reduced 16.5%	339 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.34 - $3.96 $460 - $780	-197 Reduced 32.67%	406 $1,000
Q1 2022 May 13, 2022	BUY	$3.06 - $4.89 $1,199 - $1,916	392 Added 185.78%	603 $2,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $6.07 $848 - $1,280	211 New	211 $1,000

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.